These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26071582)

  • 1. Alternative splicing of placental lactogen (CSH2) in somatotroph pituitary adenomas.
    Lekva T; Berg JP; Lyle R; Heck A; Bollerslev J; Ueland T
    Neuro Endocrinol Lett; 2015; 36(2):136-42. PubMed ID: 26071582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas.
    Lekva T; Berg JP; Lyle R; Heck A; Ringstad G; Olstad OK; Michelsen AE; Casar-Borota O; Bollerslev J; Ueland T
    Endocrinology; 2013 Sep; 154(9):3331-43. PubMed ID: 23825128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly.
    Lekva T; Berg JP; Fougner SL; Olstad OK; Ueland T; Bollerslev J
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1506-14. PubMed ID: 22585092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recovery.
    Lekva T; Berg JP; Heck A; Lyngvi Fougner S; Olstad OK; Ringstad G; Bollerslev J; Ueland T
    PLoS One; 2013; 8(6):e66927. PubMed ID: 23825587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns.
    Männik J; Vaas P; Rull K; Teesalu P; Rebane T; Laan M
    J Clin Endocrinol Metab; 2010 May; 95(5):2433-42. PubMed ID: 20233782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response.
    Fougner SL; Lekva T; Borota OC; Hald JK; Bollerslev J; Berg JP
    J Clin Endocrinol Metab; 2010 May; 95(5):2334-42. PubMed ID: 20335450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
    Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors.
    Yamato A; Nagano H; Gao Y; Matsuda T; Hashimoto N; Nakayama A; Yamagata K; Yokoyama M; Gong Y; Shi X; Zhahara SN; Kono T; Taki Y; Furuki N; Nishimura M; Horiguchi K; Iwadate Y; Fukuyo M; Rahmutulla B; Kaneda A; Hasegawa Y; Kawashima Y; Ohara O; Ishikawa T; Kawakami E; Nakamura Y; Inoshita N; Yamada S; Fukuhara N; Nishioka H; Tanaka T
    Commun Biol; 2022 Nov; 5(1):1304. PubMed ID: 36435867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas.
    Tang Y; Xie T; Wu S; Yang Q; Liu T; Li C; Liu S; Shao Z; Zhang X
    Endocrine; 2021 Nov; 74(2):375-386. PubMed ID: 34043183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
    Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
    Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential placental expression profile of human Growth Hormone/Chorionic Somatomammotropin genes in pregnancies with pre-eclampsia and gestational diabetes mellitus.
    Männik J; Vaas P; Rull K; Teesalu P; Laan M
    Mol Cell Endocrinol; 2012 May; 355(1):180-7. PubMed ID: 22387044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic abnormalities of somatostatin receptors in pituitary tumors.
    Lania A; Mantovani G; Spada A
    Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly.
    Heck A; Emblem KE; Casar-Borota O; Bollerslev J; Ringstad G
    Endocrine; 2016 May; 52(2):333-43. PubMed ID: 26475495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary.
    Yamada S; Sano T; Stefaneanu L; Kovacs K; Aiba T; Sawano S; Shishiba Y
    J Clin Endocrinol Metab; 1993 Feb; 76(2):352-6. PubMed ID: 8432778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of GH secretion by GHRH.
    Matsuno A; Katakami H; Sanno N; Ogino Y; Osamura RY; Matsukura S; Shimizu N; Nagashima T
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3241-7. PubMed ID: 10487694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly.
    Fougner SL; Casar-Borota O; Heck A; Berg JP; Bollerslev J
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):96-102. PubMed ID: 21722151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.